Open Access
Subscription or Fee Access
A Review on Treating and Managing Hypertension in Pregnancy
Abstract
Hypertension refers to increased arterial blood pressure. Studies show that disorders (pre-existing and gestational hypertension, preeclampsia, and eclampsia) due to hypertension are major cause of morbidity and mortality during pregnancy. During centuries we still do not have any specific treatment for hypertension in pregnancy. Hypertension during pregnancy occurs in about 6–8% of women. It is necessary to choose the optimal time and optimal therapy for hypertensive pregnancy disorders. Complication can be divided into maternal and fetal types. Maternal complications include haemorrhage stroke, pulmonary edema, retinopathy etc. Fetal complications include preterm delivery, intrauterine fetal demise etc. These disorders can be diagnosed by urine protein assessment, RFT, CBC with platelet count, chest radiograph, head imaging, abdominal imaging etc. The objective of treatment is to forestall critical cerebrovascular and cardiovascular occasions in the mother, without trading off fetal prosperity. The aim of present review is to report the management of pregnancy induced hypertension and methods of diagnosis for Pregnancy Induced Hypertension. The review also emphasizes on pathophysiology of hypertension.
References
American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Report of the American college of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5): 1122–1131p.
National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 1990; 163(5 Pt 1): 1691–712p.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(1): S1–S22p.
Sibai BM, Anderson GD. Pregnancy Outcome of Intensive Therapy in Severe Hypertension in First Trimester. Obstet Gynecol. 1986; 67(4): 517–22p.
Working Group on High Blood Pressure in Pregnancy and National High Blood Pressure Program Coordinating Committee: National High Blood Pressure Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(1):S1-S22..
Sergio Ferrazzani. Hypertension in Pregnancy. Saudi J Kidney Dis Transpl. 1999; 10(3): 298–312p.
The 1988 report of the Joint National Committee on Detection. Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1988; 148(5): 1023–38p.
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy: Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5): 1122–1131p.
Caruso A, Ferrazzani S, De Carolis S. Medicine maternofetale. 1994.
ElFarra J, Bean C, Martin JN. Management of Hypertensive Crisis for the Obstetrician/ Gynecologist. Obstet Gynecol Clin North Am. 2016 Dec; 43(4): 623-637p.
Haram K, Svendsen E, Abildgaard U. The HELLP Syndrome: Clinical Issues and Management. A Review. BMC Pregnancy Childbirth. Feb 2009; 9: 8p.
Habli M, Sibai BM. Hypertensive Disorders of Pregnancy. In: RS Gibbs, et al., editors. Danforth’s Obstetrics and Gynecology. 10th Edn. Philadelphia: Lippincott Williams and Wilkins; 2008; 257–275p.
Sanghavi M and Rutherford JD. Cardiovascular Physiology of Pregnancy. Circulation. 2014; 130(12): 1003–1008p.
Berkane N, Liere P, Oudinet JP, et al. From Pregnancy to Preeclampsia: A Key Role for Estrogens. Endocr Rev 2017; 38(2): 123–144p.
Conard KP. Maternal Vasodilation in Pregnancy: The Emerging Role of Relaxin. Am J Physiol Regul Integr Comp Physiol. 2011; 301(2): R267–R275p.
Kodogo V, Azibani F, Sliwa K. Role of Pregnancy Hormones and Hormonal Interaction on the Maternal Cardiovascular System: A Literature Review. Clin Res Cardiol. 2019; 108(8): 831–846p. Epub ahead of print 26 February 2019. DOI: 10.1007/s00392–019–01441–x.
Lumbers ER, Pringle KG Roles of the Circulating Renin-Angiotensin Aldosterone System in Human Pregnancy. Am J Physiol Regul Intern Comp Physiol. 2014; 306(2): R91–R101p.
Ngene NC, Moodley J. Physiology of Blood Pressure Relevant to Managing Hypertension in Pregnancy. J Matern Fetal Neonatal Med. 2019; 32(8): 1368–1377p. Epub ahead of print 27 Nov 2019. DOI: 10.1080/14767058.20171404569.
Horowitz KM, Ingardia CJ, Borgida AF. Anemia in Pregnancy. Clin Lab Med. 2013; 33(2): 281–291p.
Magee LA, Von Dadelszen P. State-of-the-Art Diagnosis and Treatment of Hypertension in Pregnancy. Mayo Clin Proc. 2018; 93(11): 1664–1677p.
Seeley EW, Ecker J. Chronic Hypertension in Pregnancy. Circulation. 2014; 129(11): 1254–1261p.
Sibai BM, Lindheimer M, Hauth J, et al. Risk Factors for Preeclampsia, Abruptio Placentae, and Adverse Neonatal Outcomes among Women with Chronic Hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998; 339(10): 667–671p.
Granger JP, Alexander BT, Bennett WA, et al. Pathophysiology of Pregnancy-Induced Hypertension. Am J Hypertens. 2001; 14(6 Pt 2): 178S–185Sp.
Ngene NC, Moodley J. Role of Angiogenic Factors in the Pathogenesis and Management of Preeclampsia. Int J Gynacol Obstet. 2018; 141(1): 5–13p.
Atallah A, Lecarpentier E, Goffinet F, et al. Aspirin for Prevention of Preeclampsia. Drugs. 2017; 77(17): 1819–1831p.
Maynard SE, Min JY, Merchan J, et al. Excess Placental Soluble fms-Like Tyrosine Kinase 1 (sFlt1) may contribute to Endothelial Dysfunction, Hypertension, and Proteinuria in Preeclampsia. J Clin Invest. 2003; 111(5): 649–658p.
Levine RJ, Maynard SE, Qian C, et al. Circulating Angiogenic Factors and the Risk of Preeclampsia. N Engl J Med. 2004; 350(7): 672–683p.
Osol G, Ko NL, Mandala M. Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia. Curr Hypertens Rep. 2017; 19(10): 82p.
Redmen CW, Staff AC. Preeclampsia, Biomarkars, Syncytiotrophoblast Stress, and Placental Capacity. Am J Obstet Gynecol. 2015; 213(4 Suppl.): S9.el, S9–S11p.
ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy. Obstet Gynecol. 2019; 133(1): e26–e50p.
Visintin C, Mugglestone MA, Almerie MQ, et al. Management of Hypertension Disorders during Pregnancy: Summary of NICE Guidance. BMJ. 2010; 341: c2207.
Bernstein PS, Martin JN Jr, Barton JR, et al. Consensus Bundle on Severe Hypertension during Pregnancy and the Postpartum Period. J Obstet Gynecol Neonatal Nurs. 2017; 46(5): 776–787p.
Varon J, Marik PE. The Diagnosis and Management of Hypertensive Crisis. Chest. 2000; 118(1): 214–227p.
Sibai BM. Chronic Hypertension in Pregnancy. Obstet Gynecol. 2002; 100(2): 369–77p.
Alexander JM, Wilson KL. Hypertension Emergencies of Pregnancy. Obstet Gynecol Clin North Am. 2013; 40(1): 89–101p.
Sibai BM, Anderson GD. Pregnancy Outcome of Intensive Therapy in Severe Hypertension in First Trimester. Obstet Gynecol. 1986; 67(4): 517–22p.
Zetterstrom K, Lindeberg SN, Haglund B, et al. Maternal Complications in Women with Chronic Hypertension: A Population-Based Cohort Study. Acta Obstet Gynecol Scand. 2005; 84(5): 419–24p.
Vanek M, Sheiner E, Levy A, et al. Chronic Hypertension and the Risk for Adverse Pregnancy Outcome after Superimposed Pre-Eclampsia. Int J Gynaecol Obstet. 2004; 86(1): 7–11p.
American College of Obstetricians and Gynecologists, Task Force on Hypertension in Pregnancy. Hypertension in Pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013; 122(5): 1122–31p.
Creasy RK, et al. Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice.8th edition. Elsevier, 2018
Nahar L, Nahar K, Hossain MI, Yasmin H, Annur BM. Placental Changes in Pregnancy Induced Hypertension and Its Impacts on Fetal Outcome. Mymensingh Med J. 2015; 24(1): 9–17p.
Bellany L, Casas JP, Hingorani AD, Williams DJ. Preeclampsia and Risk of Cardiovascular Disease and Cancer in Later Life: Systematic Review and Meta-Analysis. BMJ. 2007; 335(7627): 974p.
ONTARGET investigators, Yusuf S, Teo KK, et al. Telmisatan, Ramipril, or Both in Patients at High Risk for Vascular Events. N Engl J Med. 2008; 358: 1547–1559p.
Olsen SF, Osterdal ML, Salvig JD, Weber T, Tabor A, Secher NJ. Duration of Pregnancy in Relation to Fish Oil Supplementation and Habitual Fish Intake: A Randomised Clinical Trial with Fish Oil. Eur J Clin Nutr. 2007; 61(8): 976–985p.
Purswani JM, Gala P, Dwarkanath P, Larkin HM, Kurpad A, Mehta S. The Role of Vitamin D in Pre-Eclampsia: A Systematic Review. BMC Pregnancy Childbirth. 2017; 17(1): 231p.
Magro-Malosso ER, Saccone G, Di Tommaso M, Roman A, Berghella V. Exercise during Pregnancy and Risk of Gestational Hypertensive Disorders: A Systematic Review and Meta-Analysis. Acta Obstet Gynecol Scand. 2017; 96(8): 921–931p.
Magee LA, von DadelSzen P, Rey E, et al. Less-Tight versus Tight Control of Hypertension in Pregnancy. N Engl J Med. 2015; 372(5): 407–417p.
Molvi SN, Mir S, Rana VS, Jabeen F, Malik AR. Role of Antihypertensive Therapy in Mild to Moderate Pregnancy-Induced Hypertension: A Prospective Randomized Study Comparing Labetalol with Alpha Methyldopa. Arch Gynecol Obstet. 2012; 285(6): 1553–1562p.
Bushnell C, McCullough LD, Awad IA, et al. Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(5): 1545–1588p.
Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P. Canadian Hypertensive Disorders of Pregnancy Working Group. Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy: Executive Summary. J Obstet Gynaecol Can. 2014; 36(5): 416–441p.
European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the Management of Cardiovascular Disease during Pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J. 2011; 32(24): 3147–3197p.
Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guideline for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34(28): 2159–2219p.
Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014; 37(4): 253–390p.
August P. Lowering Diastolic Blood Pressure in Non-Proteinuric Hypertension in Pregnancy is not Harmful to the Fetus and is Associated with Reduced Frequency of Severe Maternal Hypertension. Evid Based Med. 2015; 20(4): 141p.
Plouin PF, Breart G, Maillard F, Papiernik E, Relier JP. Comparison of Antihypertensive Efficacy and Perinatal Safety of Labetalol and Methyldopa in the Treatment of Hypertension in Pregnancy: A Randomized Controlled Trial. Br J Obstet Gynaecol. 1988; 95(9): 868–876p.
Redman CW, Beilin LJ, Bonnar J. Treatment of Hypertension in Pregnancy with Methyldopa: Blood Pressure Control and Side Effects. Br J Obstet Gynaecol. 1977; 84(6): 419–426p.
Anderson GD, Carr DB. Effect of Pregnancy on the Pharmacokinetics of Antihypertensive Drugs. Clin Pharmacokinet. 2009; 48(3): 159–168p.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000; 183(1): S1–S22p.
Brown MA, Hague WM, Higgins J, et al. The Detection, Investigation and Management of Hypertension in Pregnancy: Executive Summary. Aust N Z J Obstet Gynaecol. 2000; 40(2): 133–138p.
Magee LA, Chan C, Waterman EJ, Ohlsson A, vonDadelszen P. Hydralazine for Treatment of Severe Hypertension in Pregnancy: Metaanalysis. BMJ. 2003; 327: 955–960p.
Clark SM, Dunn HE, Hankins GD. A Review of Oral Labetalol and Nifedipine in Mild to Moderate Hypertension in Pregnancy. Semin Perinatal. 2015; 39(7): 548–555p.
Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine Administered in Pregnancy: Effect on the Development of Children at 18 months. BJOG. 2000; 107(6): 792–794p.
Pickles CJ, Broughton Pipkin F, Symonds EM. A Randomised Placebo-Controlled Trial of Labetalol in the Treatment of Mild to Moderate Pregnancy Induced Hypertension. Br J Obstet Gynaecol. 1992; 99(12): 964–968p.
Pickles CJ, Symonds EM, Broughton Pipkin F. The Fetal Outcome in a Randomized Double-Blind Controlled Trial of Labetalol versus Placebo in Pregnancy-Induced Hypertension. Br J Obstet Gynaecol. 1989; 96(1): 38–43p.
Collins R, Yusuf S, Peto R. Overview of Randomised Trials of Diuretics in Pregnancy. Br Med J (Clin Res Ed). 1985; 290(6461): 17–23p.
Riester A, Reincke M. Progress in Primary Aldosteronism: Mineralocorticoid Receptor Antagonists and Management of Primary Aldosteronism in Pregnancy. Eur J Endocrinol. 2015; 172(1): R23–30p.
Freier DT, Thompson NW. Pheochromocytoma and Pregnancy: The Epitome of High Risk. Surgery. 1993; 114(6): 1148–1152p.
Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors. N Engl J Med. 2006; 354(23): 2443–2451p.
Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal Exposure to Angiotensin Converting Enzyme Inhibitors in the First Trimester and Risk of Malformations in Offspring: A Retrospective Cohort Study. BMJ. 2011; 343: d5931p.
Visintin C, Muggkestone MA, Almerie MQ, et al. Management of Hypertensive Disorders during Pregnancy: Summary of NICE Guidance. BMJ. 2010; 341: c2207p.
Refbacks
- There are currently no refbacks.
Copyright (c) 2020 Research & Reviews: Journal of Medicine